{"id":2676,"date":"2023-11-21T09:12:38","date_gmt":"2023-11-21T08:12:38","guid":{"rendered":"https:\/\/rominwest.nl\/inspiratie\/1-miljoen-euro-voor-immunotherapie-innovatie\/"},"modified":"2025-02-07T16:14:27","modified_gmt":"2025-02-07T15:14:27","slug":"1-million-euros-for-immunotherapy-innovation","status":"publish","type":"inspiratie","link":"https:\/\/rominwest.nl\/en\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/","title":{"rendered":"Ellogon receives \u20ac1,000,000 for immunotherapy innovation"},"content":{"rendered":"

EIDOSTM<\/sup> is a CE-IVDD certified solution that uses AI to select patients for immunotherapy, a relatively new cancer treatment method that has been around since 2014. The solution is one of the results of the strategic partnership for the use of AI in cancer treatments that Ellogon entered into in 2020 with the Netherlands Cancer Institute (NKI). EIDOSTM<\/sup> is not only effective, but also easy and seamless to integrate into clinical practice.<\/p>\n

Ellogon helps determine chances of success<\/span><\/b><\/h5>\n

\u201cUnfortunately, immunotherapy is not effective for everyone,\u201d explains Robert Kuipers, <\/a>CEO of Ellogon: \u201cThe result is currently lacking in approximately 30% of the patients who immunotherapy<\/a> while the therapy would probably benefit from approximately 15% of the unselected patients. Our solution could help to determine the chance of success of immunotherapy for a patient more quickly. This increases the chance of survival for the patient and makes it easier to keep healthcare costs under control.\u201d<\/p>\n

Affordable care for everyone\u00a0<\/span><\/b><\/h5>\n

Immunotherapy is currently still very expensive: costs vary from 50,000 to 200,000 euros per patient. The demand for affordable cancer treatments is growing rapidly; the number of cancer cases is expected to increase by 70% over the next twenty years. \u201cROM InWest is investing in the company because the company is using AI innovations such as EIDOSTM<\/sup><\/a> \u201cDigitalization in healthcare is accelerating,\u201d explains Janet Nieboer, CEO ROM InWest. \u201cIn doing so, they contribute to sufficient available and affordable healthcare for everyone.\u201d <\/span><\/p>\n

Immunotherapy popular<\/strong><\/span><\/h5>\n

Immunotherapy uses the patient's immune system to attack cancer cells in the body, with the aim of preventing the spread of cancer, keeping the cancer under control or eliminating it altogether. The therapy is so popular because it has a three-fold higher chance of overall survival compared to traditional treatments. Many Dutch hospitals now prescribe immunotherapy.<\/span><\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

ROM InWest, together with UvA Ventures Holding, is investing 1 million euros in Ellogon, a specialist in AI applications for healthcare. With this solution, they will continue to scale up and integrate into existing immunotherapy. Effective immunotherapy requires customization and contributes to affordable healthcare.<\/p>","protected":false},"author":4,"featured_media":2592,"template":"","tags":[47],"soort-insp":[76],"class_list":["post-2676","inspiratie","type-inspiratie","status-publish","has-post-thumbnail","hentry","tag-investeren","soort-insp-nieuws"],"yoast_head":"\nROM InWest investeert \u20ac 1.000.000 in LSH startup Ellogon<\/title>\n<meta name=\"description\" content=\"ROM InWest investeert samen met UvA Ventures Holding 1 miljoen euro in Ellogon, specialist in AI-toepassingen voor de zorg.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rominwest.nl\/en\/news\/1-million-euros-for-immunotherapy-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ellogon ontvangt \u20ac 1.000.000 voor immunotherapie-innovatie\" \/>\n<meta property=\"og:description\" content=\"ROM InWest investeert samen met UvA Ventures Holding 1 miljoen euro in Ellogon, specialist in AI-toepassingen voor de zorg.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rominwest.nl\/en\/news\/1-million-euros-for-immunotherapy-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"ROM InWest\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-07T15:14:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/03\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"890\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/\",\"url\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/\",\"name\":\"ROM InWest investeert \u20ac 1.000.000 in LSH startup Ellogon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rominwest.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rominwest.nl\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg\",\"datePublished\":\"2023-11-21T08:12:38+00:00\",\"dateModified\":\"2025-02-07T15:14:27+00:00\",\"description\":\"ROM InWest investeert samen met UvA Ventures Holding 1 miljoen euro in Ellogon, specialist in AI-toepassingen voor de zorg.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rominwest.nl\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg\",\"contentUrl\":\"https:\\\/\\\/rominwest.nl\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg\",\"width\":1280,\"height\":890,\"caption\":\"ellogon\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rominwest.nl\\\/nieuws\\\/1-miljoen-euro-voor-immunotherapie-innovatie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rominwest.nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inspiratie\",\"item\":\"https:\\\/\\\/rominwest.nl\\\/inspiratie\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ellogon ontvangt \u20ac 1.000.000 voor immunotherapie-innovatie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rominwest.nl\\\/#website\",\"url\":\"https:\\\/\\\/rominwest.nl\\\/\",\"name\":\"ROM InWest\",\"description\":\"Innoveren + Investeren\",\"publisher\":{\"@id\":\"https:\\\/\\\/rominwest.nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rominwest.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/rominwest.nl\\\/#organization\",\"name\":\"ROM InWest\",\"url\":\"https:\\\/\\\/rominwest.nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/rominwest.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/rominwest.nl\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/ROM-InWest-logo-2024-web.svg\",\"contentUrl\":\"https:\\\/\\\/rominwest.nl\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/ROM-InWest-logo-2024-web.svg\",\"width\":133,\"height\":44,\"caption\":\"ROM InWest\"},\"image\":{\"@id\":\"https:\\\/\\\/rominwest.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCn0GPDxtaucYQGVCTCNBNRg\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rom-inwest\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ROM InWest invests \u20ac1,000,000 in LSH startup Ellogon","description":"ROM InWest, together with UvA Ventures Holding, is investing 1 million euros in Ellogon, a specialist in AI applications for healthcare.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rominwest.nl\/en\/news\/1-million-euros-for-immunotherapy-innovation\/","og_locale":"en_GB","og_type":"article","og_title":"Ellogon ontvangt \u20ac 1.000.000 voor immunotherapie-innovatie","og_description":"ROM InWest investeert samen met UvA Ventures Holding 1 miljoen euro in Ellogon, specialist in AI-toepassingen voor de zorg.","og_url":"https:\/\/rominwest.nl\/en\/news\/1-million-euros-for-immunotherapy-innovation\/","og_site_name":"ROM InWest","article_modified_time":"2025-02-07T15:14:27+00:00","og_image":[{"width":1280,"height":890,"url":"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/03\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/","url":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/","name":"ROM InWest invests \u20ac1,000,000 in LSH startup Ellogon","isPartOf":{"@id":"https:\/\/rominwest.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/#primaryimage"},"image":{"@id":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/#primaryimage"},"thumbnailUrl":"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/03\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg","datePublished":"2023-11-21T08:12:38+00:00","dateModified":"2025-02-07T15:14:27+00:00","description":"ROM InWest, together with UvA Ventures Holding, is investing 1 million euros in Ellogon, a specialist in AI applications for healthcare.","breadcrumb":{"@id":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/#primaryimage","url":"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/03\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg","contentUrl":"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/03\/20231109_Press_release_-_beeld_computer_paars_cellen.jpg","width":1280,"height":890,"caption":"ellogon"},{"@type":"BreadcrumbList","@id":"https:\/\/rominwest.nl\/nieuws\/1-miljoen-euro-voor-immunotherapie-innovatie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rominwest.nl\/"},{"@type":"ListItem","position":2,"name":"Inspiratie","item":"https:\/\/rominwest.nl\/inspiratie\/"},{"@type":"ListItem","position":3,"name":"Ellogon ontvangt \u20ac 1.000.000 voor immunotherapie-innovatie"}]},{"@type":"WebSite","@id":"https:\/\/rominwest.nl\/#website","url":"https:\/\/rominwest.nl\/","name":"ROM InWest","description":"Innovate + Invest","publisher":{"@id":"https:\/\/rominwest.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rominwest.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/rominwest.nl\/#organization","name":"ROM InWest","url":"https:\/\/rominwest.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rominwest.nl\/#\/schema\/logo\/image\/","url":"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/02\/ROM-InWest-logo-2024-web.svg","contentUrl":"https:\/\/rominwest.nl\/wp-content\/uploads\/2024\/02\/ROM-InWest-logo-2024-web.svg","width":133,"height":44,"caption":"ROM InWest"},"image":{"@id":"https:\/\/rominwest.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/channel\/UCn0GPDxtaucYQGVCTCNBNRg","https:\/\/www.linkedin.com\/company\/rom-inwest\/"]}]}},"_links":{"self":[{"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/inspiratie\/2676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/inspiratie"}],"about":[{"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/types\/inspiratie"}],"author":[{"embeddable":true,"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/users\/4"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/media\/2592"}],"wp:attachment":[{"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/media?parent=2676"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/tags?post=2676"},{"taxonomy":"soort-insp","embeddable":true,"href":"https:\/\/rominwest.nl\/en\/wp-json\/wp\/v2\/soort-insp?post=2676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}